Clinical Trial Update: Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer [Phase 3]

View source ↗

Summary

Ongoing Phase 3 clinical trial evaluating the combination of Tumor Treating Fields with gemcitabine and nab-paclitaxel as first-line therapy for locally advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemcitabine (Gemcitabine)
• Tumor Treating Fields (tumor treating fields)

Snippet

Sponsor: Jiangsu Healthy Life Innovation Medical Technology Co., Ltd | Conditions: Locally Advanced Pancreatic Cancer | Phase 3 | Status: RECRUITING